F. Dromer, S. Mathoulin-pélissier, O. Launay, and O. Lortholary, Determinants of Disease 468 Presentation and Outcome during Cryptococcosis: The CryptoA/D Study, PLoS Med, vol.469, issue.2, p.21, 2007.

. Perfect, S. D. Lang, and D. T. Durack, Chronic cryptococcal meningitis: a new experimental model 471 in rabbits, The American journal of pathology, vol.101, issue.1, p.194, 1980.

A. Casadevall, J. N. Steenbergen, and J. D. Nosanchuk, Ready made' virulence and 'dual use' 473 virulence factors in pathogenic environmental fungi -the Cryptococcus neoformans paradigm

, Curr Opin Microbiol, vol.6, issue.4, pp.332-337, 2003.

K. L. Wozniak and S. M. Levitz, Cryptococcus neoformans Enters the Endolysosomal Pathway of 476

, Dendritic Cells and Is Killed by Lysosomal Components, Infect Immun, vol.76, issue.10, pp.4764-4771, 2008.

J. W. Murphy, A. Zhou, and S. C. Wong, Direct interactions of human natural killer cells with 478

, Cryptococcus neoformans inhibit granulocyte-macrophage colony-stimulating factor and tumor 479 necrosis factor alpha production, Infection and Immunity, vol.65, issue.11, p.4571, 1997.

B. C. Fries, C. P. Taborda, E. Serfass, and A. Casadevall, Phenotypic switching of Cryptococcus 481 neoformans occurs in vivo and influences the outcome of infection, J Clin Invest, vol.482, issue.11, pp.1639-1648, 2001.

M. Feldmesser, Y. Kress, P. Novikoff, and A. Casadevall, Cryptococcus neoformans is a facultative 484 intracellular pathogen in murine pulmonary infection, Infection and Immunity, vol.68, issue.7, p.4225, 2000.

A. Alanio, M. Desnos-ollivier, and F. Dromer, Dynamics of Cryptococcus neoformans-Macrophage 487

, Interactions Reveal that Fungal Background Influences Outcome during Cryptococcal 488 Meningoencephalitis in Humans, mBio, vol.2, issue.4, pp.158-169, 2011.

M. Alvarez and A. Casadevall, Cell-to-cell spread and massive vacuole formation after 43. Kanj SS et al. Fungal Infections in Lung and Heart-Lung Transplant Recipients: Report of 9 574 Cases and Review of the Literature, Medicine, vol.75, issue.3, pp.142-156, 1996.

B. S. Ooi, B. Chen, . Limch, O. T. Khoo, and K. T. Chan, Survival of a patient transplanted with a 576 kidney infected with Cryptococcus neoformans, Transplantation, vol.11, issue.4, p.428, 1971.

J. W. Baddley, Transmission of Cryptococcus neoformans by Organ Transplantation, Clin 578 Infect Dis, vol.52, issue.4, pp.94-102, 2011.

F. Ye, Retrospective Analysis of 76 Immunocompetent Patients with Primary Pulmonary 580

, Cryptococcosis. Lung, vol.190, issue.3, pp.339-346, 2012.

Y. Zeng, Clinicopathologic and Ultrastructural Study of Non-HIV-related Primary 582

, Pulmonary Cryptococcosis in China: Report of 43 Cases, Ultrastruct Pathol, vol.35, issue.1, pp.19-25, 2011.

F. Setianingrum, R. Rautemaa-richardson, and D. W. Denning, Pulmonary cryptococcosis: A review 584 of pathobiology and clinical aspects, Med Mycol, vol.57, issue.2, pp.133-150, 2018.

J. C. Christianson, W. Engber, and D. Andes, Primary cutaneous cryptococcosis in 586 immunocompetent and immunocompromised hosts, Med Mycol, vol.41, issue.3, pp.177-188, 2003.

S. Neuville, Primary Cutaneous Cryptococcosis: A Distinct Clinical Entity, Clin Infect Dis, vol.588, issue.3, pp.337-347, 2003.

S. S. Giles, T. Dagenais, M. R. Botts, N. P. Keller, and C. M. Hull, Elucidating the pathogenesis of 590 spores from the human fungal pathogen Cryptococcus neoformans, Infect Immun, vol.591, issue.8, p.3500, 2009.

D. L. Goldman, Serologic evidence for Cryptococcus neoformans infection in early 593 childhood, Pediatrics, vol.107, issue.5, p.66, 2001.

F. Bao, H. Tan, W. Liu, Y. Li, and H. Li, Pediatric Cryptococcal Lymphadenitis in the Absence of AIDS: 607 Case Report and Literature Review, Case Reports Pediatrics, vol.2013, pp.1-4, 2013.

J. Gurung, W. V. Lyngdoh, and A. B. Khyriem, Isolated cervical cryptococcal lymphadenitis without 609 meningitis in an immunocompetent human immunodeficiency virus-negative child: a rare case 610 report, Jmm Case Reports, vol.1, issue.3, 2014.

D. K. Jha, A. K. Jha, and R. K. Singh, An atypical initial presentation of AIDS as cryptococcal 612 lymphadenitis, Oxf Medical Case Reports, issue.11, 2018.

S. Chauhan, A Rare Case of Primary Supraclavicular Lymphadenitis Due to Cryptococcus 614 neoformans in an HIV Infected Patient, J Clin Diagnostic Res, vol.8, issue.2, pp.137-138, 2014.

P. Dogbey, M. Golden, and N. Ngo, Cryptococcal lymphadenitis: an unusual initial presentation of 616 HIV infection, Bmj Case Reports, p.2013010316, 2013.

K. Kawamoto, Clinicopathological features of cryptococcal lymphadenitis and a review 618 of literature, J Clin Exp Hematop, 2017.

L. Putignani, Cryptococcal Lymphadenitis as a Manifestation of Immune Reconstitution 620

, Inflammatory Syndrome in an HIV-Positive Patient: A Case Report and Review of the Literature

, Int J Immunopath Ph, vol.21, issue.3, pp.751-756, 2008.

V. Jagadha, R. H. Andavolu, and C. T. Huang, Granulomatous Inflammation in the Acquired Immune 623 Deficiency Syndrome, Am J Clin Pathol, vol.84, issue.5, pp.598-602, 1985.

J. O. Hill, CD4+ T cells cause multinucleated giant cells to form around Cryptococcus 625 neoformans and confine the yeast within the primary site of infection in the respiratory tract, J 626 Exp Medicine, vol.175, issue.6, pp.1685-1695, 1992.

D. Garcia-hermoso, G. Janbon, and F. Dromer, Epidemiological evidence for dormant 628

, Cryptococcus neoformans infection, Journal of Clinical Microbiology, vol.37, issue.10, pp.3204-3209, 1999.

D. C. Saha, Serologic Evidence for Reactivation of Cryptococcosis in Solid, Organ, vol.630

, Transplant Recipients. Clin Vaccine Immunol, vol.14, issue.12, pp.1550-1554, 2007.

F. Dromer, O. Ronin, and B. Dupont, Isolation of Cryptococcus neoformans var. gattii from an Asian 632 patient in France: evidence for dormant infection in healthy subjects, Journal of medical and 633 veterinary mycology, vol.30, issue.5, pp.395-397, 1992.

C. A. Liechty, Asymptomatic serum cryptococcal antigenemia and early mortality during 635 antiretroviral therapy in rural Uganda, Trop Med Int Health, vol.12, issue.8, pp.929-935, 2007.

A. O. Andama, Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive 637 patients hospitalized for suspected tuberculosis in Uganda, Jaids J Acquir Immune Defic 638 Syndromes, vol.63, issue.2, p.194, 2013.

E. Temfack, Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral, vol.643

, Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS 644, Test. Front Microbiol, vol.09, p.409, 2018.

T. B. Chammard, E. Temfack, O. Lortholary, and A. Alanio, Diagnostic and therapeutic strategies in 646 cryptococcosis: impact on outcome, Memórias Instituto Oswaldo Cruz, vol.113, issue.7, p.180050, 2018.

M. Shi, Real-time imaging of trapping and urease-dependent transmigration of 648

, Cryptococcus neoformans in mouse brain, J Clin Invest, vol.120, issue.5, pp.1683-1693, 2010.

M. Shi, P. Colarusso, P. Calaruso, and C. H. Mody, Real-time in vivo imaging of fungal migration to 650 the central nervous system, Cell Microbiol, vol.14, issue.12, pp.1819-1827, 2012.

N. French, Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults, Aids, vol.652, issue.7, pp.1031-1038, 2002.

J. R. Perfect, Clinical Practice Guidelines for the Management of Cryptococcal Disease: 654 2010 Update by the Infectious Diseases Society of, America, vol.50, issue.3, pp.291-322, 2010.

S. F. Molloy, Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa

, New Engl J Medicine, vol.378, issue.11, pp.1004-1017, 2018.

J. N. Day, Combination Antifungal Therapy for Cryptococcal Meningitis, New Engl J Med, vol.658, issue.14, pp.1291-1302, 2013.

X. Ou, Genotypes Coding for Mannose-Binding Lectin Deficiency Correlated With 660

, Cryptococcal Meningitis in HIV-Uninfected Chinese Patients, J Infect Dis, vol.203, issue.11, pp.1686-661, 2011.

W. Sabiiti, Efficient phagocytosis and laccase activity affect the outcome of HIV-663 associated cryptococcosis, J Clin Invest, vol.124, issue.5, pp.2000-2008, 2014.

J. V. Gray, The viability and virulence of old cultures of tubercle bacilli, Microbiol Mol Biol, vol.87, issue.11, pp.232-237, 1951.

M. Gengenbacher, S. Rao, K. Pethe, T. Dick, S. H. Lillie et al., Reserve carbohydrate metabolism in Saccharomyces cerevisiae: 678 responses to nutrient limitation, J Bacteriol, vol.143, issue.3, pp.1384-94, 1980.

D. J. Jamieson, Oxidative stress responses of the yeast Saccharomyces cerevisiae, Yeast, vol.680, issue.16, pp.1511-1527, 1998.

G. S. Davidson, The proteomics of quiescent and nonquiescent cell differentiation in yeast 682 stationary-phase cultures, Mol Biol Cell, vol.22, issue.7, pp.988-998, 2011.

K. Takeo, R. Tanaka, M. Miyaji, and K. Nishimura, Unbudded G 2 as well as Gj arrest in the stationary 684 phase of the basidiomycetous yeast Cryptococcus neoformans, Fems Microbiol Lett, vol.129, issue.2-685 3, pp.231-235, 1995.

T. Mocluzuki, S. Tanaka, Y. Saito, and S. Watanabe, Mitochondrial Kinetics During Mitosis in 687

, Cryptococcus neoformans an Ultrastructural Study, Mycoses, vol.32, issue.1, pp.7-13, 1989.

B. Hommel, Cryptococcus neoformans resists to drastic conditions by switching to viable 689 but non-culturable cell phenotype, PLoS Pathog, vol.15, issue.7, p.1007945, 2019.

R. D. Diamond, R. K. Root, and J. E. Bennett, Factors influencing killing of Cryptococcus neoformans 691 by human leukocytes in vitro, The Journal of Infectious Diseases, vol.125, issue.4, pp.367-376, 1972.

L. Green, B. Petersen, L. Steimel, P. Haeber, and W. Current, Rapid determination of antifungal 693 activity by flow cytometry, J Clin Microbiol, vol.32, issue.4, pp.1088-91, 1994.

A. M. Nicola, E. J. Robertson, P. Albuquerque, S. Derengowski-l-da, and A. Casadevall, Nonlytic 695

, Exocytosis of Cryptococcus neoformans from Macrophages Occurs In Vivo and Is Influenced by 696 Phagosomal pH, mBio, vol.2, issue.4, pp.167-178, 2011.

J. M. Hardwick, Do Fungi Undergo Apoptosis-Like Programmed Cell Death?, mBio, vol.698, issue.4, pp.948-966, 2018.

C. P. Semighini, A. F. Averette, J. R. Perfect, and J. Heitman, Deletion of Cryptococcus neoformans apoptosis-like programmed cell death, Science, vol.360, issue.6395, p.6910, 2018.

L. Goulart, Cryptococcus neoformans and Cryptococcus gattii genes preferentially 705 expressed during rat macrophage infection, Med Mycol, vol.48, issue.7, pp.932-941, 2010.

Y. Chen, The Cryptococcus neoformans Transcriptome at the Site of Human Meningitis, 707 mBio, vol.5, issue.1, pp.1087-1100, 2014.

M. Gengenbacher and S. Kaufmann, Mycobacterium tuberculosis: success through 709 dormancy, Fems Microbiol Rev, vol.36, issue.3, pp.514-532, 2012.

M. Salma, S. Rousseaux, A. Grand, B. Divol, and H. Alexandre, Characterization of the Viable 713 but Nonculturable (VBNC) State in Saccharomyces cerevisiae, PLoS One, vol.8, issue.10, p.77600, 2013.

D. A. Mills, E. A. Johannsen, and L. Cocolin, Yeast Diversity and Persistence in Botrytis-Affected 715

, Wine Fermentations. Appl Environ Microb, vol.68, issue.10, pp.4884-4893, 2002.

W. Toit, I. S. Pretorius, and A. Lonvaud-funel, The effect of sulphur dioxide and oxygen on the 717 viability and culturability of a strain of Acetobacter pasteurianus and a strain of Brettanomyces 718 bruxellensis isolated from wine, J Appl Microbiol, vol.98, issue.4, pp.862-871, 2005.

K. L. Liew, J. M. Jee, I. Yap, and P. Yong, In Vitro Analysis of Metabolites Secreted during Infection 720 of Lung Epithelial Cells by Cryptococcus neoformans, PLoS One, vol.11, issue.4, p.153356, 2016.

P. Albuquerque, Quorum Sensing-Mediated, Cell Density-Dependent Regulation of 722 Growth and Virulence in Cryptococcus neoformans, mBio, vol.5, issue.1, pp.986-999, 2014.

M. Nofal, K. Zhang, S. Han, and J. D. Rabinowitz, mTOR Inhibition Restores Amino Acid Balance in 724

, Cells Dependent on Catabolism of Extracellular Protein. Mol Cell, vol.67, issue.6, pp.936-946, 2017.

D. L. Martinez, Y. Tsuchiya, and I. Gout, Coenzyme A biosynthetic machinery in mammalian cells

, Biochem Soc T, vol.42, issue.4, pp.1112-1117, 2014.

K. Lewis, Persister cells, dormancy and infectious disease, Nat Rev Microbiol, vol.728, issue.1, p.1557, 2007.

J. Kim and T. K. Wood, Persistent Persister Misperceptions. Front Microbiol, vol.07, p.2134, 2016.

M. Ayrapetyan, T. C. Williams, R. Baxter, and J. D. Oliver, Viable but Nonculturable and Persister Cells 731

, Coexist Stochastically and Are Induced by Human Serum. Infect Immun, vol.83, issue.11, pp.4194-4203, 2015.

M. D. Lafleur, C. A. Kumamoto, and K. Lewis, Candida albicans Biofilms Produce Antifungal-733

, Tolerant Persister Cells?. Antimicrob Agents Ch, vol.50, issue.11, pp.3839-3846, 2006.

M. D. Lafleur, Q. Qi, and K. Lewis, Patients with Long-Term Oral Carriage Harbor High-Persister